-
10 Ways to Communicate Better with your Doctor at your Next Office Visit
Beth Waldron, Program Director of Clot Connect writes… Research has shown that effective communication between a patient and their doctor can improve the patient’s health outcome.[i] If you have been diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE), you understandably have many questions. In an ideal world, a health care provider would have…
-
Chronic Lung Damage after PE – Pulmonary Hypertension (CTEPH)
Blood clots in the lung (pulmonary embolism, PE) often completely dissolve within a few weeks or months and a patient’s symptoms of shortness and breath and chest pain disappear. Many people return to their normal self and have no physical limitations thereafter. Other people have some residual symptoms of shortness of breath or chest discomfort,…
-
Incidentally Discovered DVT, PE or Other Clots
General comments CT or MRI scans will occasionally detect an incidental iliofemoral DVT, PE or intra-abdominal thrombosis (IVC, portal, splenic, mesenteric or renal vein). This is particularly common in cancer patients undergoing staging CT scans. When such an incidental, asymptomatic venous thromboembolism (VTE) is discovered, the question arises whether the patient should be treated with…
-
Incidentally Discovered Blood Clots
General comments CT scans and MRI scans are often done in medicine, for a variety of reasons. Every so often such a scan will detect a blood clot in a patient who has no symptoms from the clot. This is referred to as an “incidental VTE” (VTE = venous thromboembolism, i.e. clot in a vein)…
-
DVT and PE: How Long to Treat With Anticoagulants?
Explanation for Patients The complex topic of “Length of Anticoagulant Treatment” for patients with VTE is being addressed in a blog entry written for patients, found on the Clot Connect patient education blog (here). For the Health Care Professional Well respected treatment guidelines exist [ref 1,2].
-
DVT and PE: How Long to Treat with “Blood Thinners”
What Kind of Clot did You Have? If you have had a blood clot in your legs or your lung (pulmonary embolism=PE), you will wonder how long you should stay on a “blood thinner”. The decision depends on a number of factors which will be discussed below.
-
Apixaban (Eliquis®) – Another New Oral Anticoagulant
Good news. Another one of the new oral anticoagulants in development, Apixaban (Eliquis®), has moved forward. On May 20th, 2011, the European Medicines Agency (EMA) approved Eliquis® for DVT prevention after orthopedic surgery (hip and knee replacement) in the 27 countries of the European Community. In the U.S., however, Eliquis® is still some way away from getting FDA approval
-
What Causes Clots? – A Family Study
Background It is known that the risk for blood clots in the leg (DVT) and lung (PE) is partly inherited. Some genes that increase the risk for DVT and PE are known (e.g. factor V Leiden, the factor II 20210 mutation, protein, protein C, S and antithrombin mutations). However, it is suspected that many other and,…
A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center
Clot Connect 